Increased Argonaute 2 Expression in Gliomas and its Association with Tumor Progression and Poor Prognosis |
Feng, Bo
(Department of Neurology, Hospital Affiliated to Binzhou medical University)
Hu, Peng (Department of Spine, Hospital Affiliated to Binzhou medical University) Lu, Shu-Jun (Department of Neurology, Hospital Affiliated to Binzhou medical University) Chen, Jin-Bo (Department of Neurology, Hospital Affiliated to Binzhou medical University) Ge, Ru-Li (Department of Neurology, Hospital Affiliated to Binzhou medical University) |
1 | Zhang R, Su B (2009). Small but influential: the role of microRNAs on gene regulatory network and 3'UTR evolution. J Genet Genomics, 36, 1-6. DOI ScienceOn |
2 | Zhou X, Guo H, Chen K, et al (2010). Identification, chromosomal mapping and conserved synteny of porcine Argonaute family of genes. Genetica, 138, 805-12. DOI |
3 | Plummer PN, Freeman R, Taft RJ, et al (2013). MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res, 73, 341-52. |
4 | Li W, Liu M, Feng Y, et al (2013). Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma. Int J Clin Exp Pathol, 6, 1086-94. |
5 | Maqbool R, Hussain MU (2014). MicroRNAs and human diseases: diagnostic and therapeutic potential. Cell Tissue Res. |
6 | O'Carroll D, Mecklenbrauker I, Das PP, et al (2007). A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev, 21, 1999-2004. DOI |
7 | Sasaki T, Shiohama A, Minoshima S, et al (2003). Identification of eight members of the Argonaute family in the human genome small star, filled. Genomics, 82, 323-30. DOI ScienceOn |
8 | Schwarzenbach H, Nishida N, Calin GA, et al (2014). Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. |
9 | Wang JB, Dong DF, Wang MD, et al (2014). IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in glioma cells in vitro and in vivo. Asian Pac J Cancer Prev, 15, 427-32. 과학기술학회마을 DOI |
10 | Yang FQ, Huang JH, Liu M, et al (2013). Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder. Int J Clin Exp Pathol, 7, 340-7. |
11 | Yoo NJ, Hur SY, Kim MS, et al (2010). Immunohistochemical analysis of RNA-induced silencing complex-related proteins AGO2 and TNRC6A in prostate and esophageal cancers. APMIS, 118, 271-6. DOI |
12 | Zhang J, Fan XS, Wang CX, et al (2013a). Up-regulation of Ago2 expression in gastric carcinoma. Med Oncol, 30, 628. DOI |
13 | Arshad H, Ahmad Z, Hasan SH (2010). Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival. Asian Pac J Cancer Prev, 11, 1637-40. |
14 | Chen DQ, Yao DX, Zhao HY, et al (2012). DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. Asian Pac J Cancer Prev, 13, 2791-4. DOI ScienceOn |
15 | Cheng N, Li Y, Han ZG (2013). Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma. Hepatology, 57, 1906-18. DOI |
16 | Dellaretti M, Reyns N, Touzet G, et al (2012). Diffuse brainstem glioma: prognostic factors. J Neurosurg, 117, 810-4. DOI |
17 | Demuth T, Berens ME (2004). Molecular mechanisms of glioma cell migration and invasion. J Neurooncol, 70, 217-28. DOI ScienceOn |
18 | Zhang X, Graves P, Zeng Y (2013b). Overexpression of human Argonaute2 inhibits cell and tumor growth. Biochim Biophys Acta, 1830, 2553-61. DOI |
19 | Farazi TA, Hoell JI, Morozov P, et al (2013). MicroRNAs in human cancer. Adv Exp Med Biol, 774, 1-20. DOI ScienceOn |
20 | Johnson DR, Galanis E (2013). Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep, 15, 56-63. DOI |
21 | Ye S, Rong J, Huang SH, et al (2012). XRCC1 and ADPRT polymorphisms associated with survival in breast cancer cases treated with chemotherapy. Asian Pac J Cancer Prev, 13, 4923-6. 과학기술학회마을 DOI |
![]() |